# Correction: Pharmacokinetic evaluation of single-dose migalastat in non-Fabry disease subjects with ESRD receiving dialysis treatment, and use of modeling to select dose regimens in Fabry disease subjects with ESRD receiving dialysis treatment

**Authors:** Franklin K. Johnson, Shirley Wu, Ginny Schmith, Hadis Williams, Jasmine Rutecki, Atef Halabi, Thorsten Feldkamp, Anthony Sileno

PMC · DOI: 10.1371/journal.pone.0322315 · 2025-04-08

## Full-text entities

- **Diseases:** ESRD (MESH:D007676), Fabry disease (MESH:D000795)
- **Chemicals:** migalastat (MESH:C090092)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11978047/full.md

---
Source: https://tomesphere.com/paper/PMC11978047